Current perspectives of enteric fever: a hospital-based study from India
Authors:
- Rajni GaindRGRajni Gaind
- Rajesh MehtaRMRajesh Mehta
- Premila PaulPPPremila Paul
- Pushpa AggarwalPAPushpa Aggarwal
- Mani KalaivaniMKMani Kalaivani
- 1 September 2005
- journal article
- Published by Taylor & Francis in Paediatrics and International Child Health
- Vol. 25 (3) , 161-174
Abstract
The last two decades have seen a change in the pattern of enteric fever with the emergence of multidrug-resistant strains (MDRS), particularly strains resistant to nalidixic acid. The aim of the study was to undertake a retrospective analysis of blood culture-confirmed cases of enteric fever diagnosed at Safdarjang Hospital, New Delhi, India from January 2001 to December 2003. The epidemiological details, clinical features, treatment outcome and antimicrobial resistance patterns were studied. Of 377 blood culture-positive cases, 80.6% were Salmonella typhi and 19.4% Salmonella paratyphi A; 21.7% were children aged under 5 years and 6.1% were under 2 years. A significant decline in MDRS was observed, from 21.9% in 2001 to 12.4% in 2003 (p=0.04). There was a significant increase in nalidixic acid-resistant Salmonella (NARS) from 56.9% in 2001 to 88.9% in 2003 (p=0.0001). Complete resistance to ciprofloxacin (MIC>4 microg/ml) was detected in only two isolates, both Salmonella paratyphi A. Minimal inhibitory concentrations (MICs) of ciprofloxacin for NARS were increased (0.125-0.5 microg/ml) but were within National Committee for Clinical Laboratory Standards susceptibility ranges. NARS had a significantly longer fever defervescence time (7.7 vs 4.7 days, p<0.001) and hospital stay (12.1 vs 8.2 days, p<0.001), and higher rates of complications (55.5% vs 24.0%, p=0.014) and mortality than nalidixic acid-sensitive Salmonella (NASS). The rate of isolation of MDRS was higher in NARS than NASS (18.8% vs 7.3%, p=0.013). The high rate of occurrence of enteric fever in children <5 years and also of infections caused by Salmonella paratyphi A in India calls for critical re-assessment of vaccination strategy. Nalidixic acid resistance and rising MICs of fluoroquinolones in Salmonella spp pose a new global threat requiring debate on the optimum treatment of enteric fever.Keywords
This publication has 30 references indexed in Scilit:
- Bacteremic Typhoid Fever in Children in an Urban Slum, BangladeshEmerging Infectious Diseases, 2005
- Decreased Susceptibility to Ciprofloxacin inSalmonella entericaserotype Typhi, United KingdomEmerging Infectious Diseases, 2001
- Typhoid fever in Bangladesh: implications for vaccination policyThe Pediatric Infectious Disease Journal, 2001
- Laboratory-Based Surveillance of Salmonella Serotype Typhi Infections in the United StatesJAMA, 2000
- Typhoid fever in children aged less than 5 yearsThe Lancet, 1999
- A HIGHLY CEFTRIAXONE-RESISTANT SALMONELLA TYPHI IN BANGLADESHThe Pediatric Infectious Disease Journal, 1999
- Epidemic ciprofloxacin-resistant Salmonella typhi in TajikistanThe Lancet, 1998
- Eradication of a multiple drug resistant Salmonella paratyphi A causing meningitis with ciprofloxacinJournal of Infection, 1992
- Patterns of Morbidity and Mortality in Typhoid Fever Dependent on Age and Gender: Review of 552 Hopitalized Patients with DiarrheaClinical Infectious Diseases, 1990
- Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 yearsThe Journal of Pediatrics, 1984